Non-invasive Detection of Iron Deficiency in Obstetrics
PICCOLINO
Point-of-care Transcutaneous Longitudinal Non-invasive Detection of Iron Deficiency in Obstetrics (PICCOLINO-Trial)
1 other identifier
observational
500
1 country
1
Brief Summary
Validation of non-invasive measurement of zinc protoporphyrin for detection of iron deficiency in pregnancy. In addition, the impact of iron deficiency on the incidence of postpartum depression, restless legs syndrome, obstetric complications and quality of life will be examined.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 12, 2022
CompletedStudy Start
First participant enrolled
November 15, 2022
CompletedFirst Posted
Study publicly available on registry
July 24, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
July 24, 2025
July 1, 2025
4.1 years
November 12, 2022
July 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Accuracy of non-invasive zinc protoporphyrin for the detection of iron deficiency in pregnancy
To validate accuracy of non-invasively measured ZnPP for detection of iron deficiency in pregnancy at prespecified timepoints
through study completion, up to 3 months postpartum
Secondary Outcomes (4)
Influence of iron status on quality of life of pregnant women
through study completion, up to 3 months postpartum
Influence of iron status on incidence of postpartum depression
through study completion, up to 3 months postpartum
Influence of iron status on incidence of restless legs syndrome among pregnant women
through study completion, up to 3 months postpartum
Influence of iron status on incidence of preterm birth
peripartum ( about 20 weeks of pregnancy until approximately 6 weeks after delivery. )
Study Arms (1)
pregnant women
Interventions
validation of non-invasive measurement of zink protoporphyrin
Eligibility Criteria
pregnant women ≥ 18 years
You may qualify if:
- any timepoint during or up to 3 months after pregnancy
- age ≥ 18 years
- written informed consent
You may not qualify if:
- previous participation in this study
- refusal of blood sampling
- incapacity to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Würzburg
Würzburg, Bavaria, 97080, Germany
Biospecimen
blood samples
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr. P. Kranke
Study Record Dates
First Submitted
November 12, 2022
First Posted
July 24, 2025
Study Start
November 15, 2022
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
July 24, 2025
Record last verified: 2025-07